PointState Capital’s Elevance Health ELV Stock Holding History

PointState Capital’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-37,500	Closed	-$14M	–	138
2021 Q3	$14M	Buy	+37,500	New	+$14.3M	0.23%	67
2021 Q2	–	Sell	-13,600	Closed	-$4.88M	–	146
2021 Q1	$4.88M	Sell	13,600 -3,191	-19%	-$1.03M	0.1%	99
2020 Q4	$5.39M	Sell	16,791 -76,221	-82%	-$23.4M	0.1%	90
2020 Q3	$25M	Buy	93,012 +2,361	+3%	+$635K	0.66%	35
2020 Q2	$23.8M	Buy	+90,651	New	+$24.2M	0.72%	32
2019 Q3	–	Sell	-212,527	Closed	-$60M	–	121
2019 Q2	$60M	Sell	212,527 -199,997	-48%	-$54.6M	1.26%	28
2019 Q1	$118M	Buy	412,524 +354,424	+610%	+$103M	2.34%	13
2018 Q4	$15.3M	Buy	+58,100	New	+$16M	0.61%	32

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

PointState Capital's ELV Position: Q4 2021 in Review

PointState Capital sold out of Elevance Health (ELV) in Q4 2021, closing a stake of 37,500 shares — an estimated $14M sold.

PointState Capital first reported a position in ELV in Q4 2018 and held it in 8 quarters. The position peaked at $118M in Q1 2019. 1,372 funds tracked by Wall St. Rank hold ELV as of Q4 2021.

PointState Capital reported no remaining Elevance Health position as of Q4 2021 after selling out during the quarter.
PointState Capital sold 37,500 Elevance Health shares in Q4 2021, an estimated $14M.
PointState Capital first reported a position in Elevance Health in Q4 2018 and held it in 8 quarters.
PointState Capital's Elevance Health position peaked at $118M in Q1 2019.
1,372 funds tracked by Wall St. Rank held Elevance Health as of Q4 2021.

Based on PointState Capital's 13F filing for Q4 2021, filed 11 Feb 2022.